Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C14H16N2O2 |
| Molecular Weight | 244.289 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 3 / 3 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
O=C(N[C@@H]1C[C@H]1C2=CC=CC=C2)[C@@H]3CCC(=O)N3
InChI
InChIKey=UGSLDMJXBQKDCT-SDDRHHMPSA-N
InChI=1S/C14H16N2O2/c17-13-7-6-11(15-13)14(18)16-12-8-10(12)9-4-2-1-3-5-9/h1-5,10-12H,6-8H2,(H,15,17)(H,16,18)/t10-,11-,12+/m0/s1
| Molecular Formula | C14H16N2O2 |
| Molecular Weight | 244.289 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 3 / 3 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Rolicyprine (EX-4883) is an antidepressant. This compound is a potent inhibitor of monoamine oxidase in vivo. One study found that rolicyprine must be biotransformed before it is a pharmacologically active compound. Once it is activated, Rolicyprine appears to have a pharmacology like that of the antidepressant tranylcypromine. It was suggested that the products of this biotransformation are tranylcypromine and pyrrolidone carboxylic acid. No information on current use of rolicyprine is available.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:01:04 GMT 2025
by
admin
on
Mon Mar 31 19:01:04 GMT 2025
|
| Record UNII |
469743E26J
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C667
Created by
admin on Mon Mar 31 19:01:04 GMT 2025 , Edited by admin on Mon Mar 31 19:01:04 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
2829-19-8
Created by
admin on Mon Mar 31 19:01:04 GMT 2025 , Edited by admin on Mon Mar 31 19:01:04 GMT 2025
|
PRIMARY | |||
|
100000084351
Created by
admin on Mon Mar 31 19:01:04 GMT 2025 , Edited by admin on Mon Mar 31 19:01:04 GMT 2025
|
PRIMARY | |||
|
CHEMBL2107038
Created by
admin on Mon Mar 31 19:01:04 GMT 2025 , Edited by admin on Mon Mar 31 19:01:04 GMT 2025
|
PRIMARY | |||
|
469743E26J
Created by
admin on Mon Mar 31 19:01:04 GMT 2025 , Edited by admin on Mon Mar 31 19:01:04 GMT 2025
|
PRIMARY | |||
|
m453
Created by
admin on Mon Mar 31 19:01:04 GMT 2025 , Edited by admin on Mon Mar 31 19:01:04 GMT 2025
|
PRIMARY | Merck Index | ||
|
C97712
Created by
admin on Mon Mar 31 19:01:04 GMT 2025 , Edited by admin on Mon Mar 31 19:01:04 GMT 2025
|
PRIMARY | |||
|
1629
Created by
admin on Mon Mar 31 19:01:04 GMT 2025 , Edited by admin on Mon Mar 31 19:01:04 GMT 2025
|
PRIMARY | |||
|
DTXSID7046259
Created by
admin on Mon Mar 31 19:01:04 GMT 2025 , Edited by admin on Mon Mar 31 19:01:04 GMT 2025
|
PRIMARY | |||
|
SUB10366MIG
Created by
admin on Mon Mar 31 19:01:04 GMT 2025 , Edited by admin on Mon Mar 31 19:01:04 GMT 2025
|
PRIMARY | |||
|
76967371
Created by
admin on Mon Mar 31 19:01:04 GMT 2025 , Edited by admin on Mon Mar 31 19:01:04 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |